Astrocytes: Key Regulators of Neuroinflammation

Trends in Immunology

Volumn 37, Issue 9, 2016, Pages 608-620

  Colombo, Emanuela ^a   Farina, Cinthia ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR; HORMONE; NEUROTROPHIN; SPHINGOLIPID; TRANSCRIPTION FACTOR;

ASTROCYTE; CELL COMMUNICATION; CELL FUNCTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIGAND BINDING; MEDIATOR RELEASE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; REVIEW; TRANSCRIPTION REGULATION; ADAPTIVE IMMUNITY; ANIMAL; ANIMAL MODEL; GENE EXPRESSION REGULATION; IMMUNOLOGY; IMMUNOMODULATION; INNATE IMMUNITY; MOUSE; NEUROGENIC INFLAMMATION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ADAPTIVE IMMUNITY; ANIMALS; ASTROCYTES; CELL COMMUNICATION; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; MICE; MICE, TRANSGENIC; MODELS, ANIMAL; NEUROGENIC INFLAMMATION; NEUROIMMUNOMODULATION; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION;

EID: 84992504899     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2016.06.006     Document Type: Review

References (102)

1. 1 Sofroniew, M.V., Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 32 (2009), 638–647.
2. 2 Cordiglieri, C., Farina, C., Astrocytes Exert and Control Immune Responses in the Brain. Curr. Immunol. Rev. 6 (2010), 150–159.
3. 3 Farina, C., et al. Astrocytes are active players in cerebral innate immunity. Trends Immunol. 28 (2007), 138–145.
4. 4 Rolls, A., et al. The bright side of the glial scar in CNS repair. Nat. Rev. Neurosci. 10 (2009), 235–241.
5. 5 Gotz, M., Huttner, W.B., The cell biology of neurogenesis. Nat. Rev. Mol. Cell Biol. 6 (2005), 777–788.
6. 6 Pekny, M., et al. Mice lacking glial fibrillary acidic protein display astrocytes devoid of intermediate filaments but develop and reproduce normally. EMBO J. 14 (1995), 1590–1598.
7. 7 Liedtke, W., et al. GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron 17 (1996), 607–615.
8. 8 Liedtke, W., et al. Experimental autoimmune encephalomyelitis in mice lacking glial fibrillary acidic protein is characterized by a more severe clinical course and an infiltrative central nervous system lesion. Am. J. Pathol. 152 (1998), 251–259.
9. 9 Stenzel, W., et al. The intermediate filament GFAP is important for the control of experimental murine Staphylococcus aureus-induced brain abscess and Toxoplasma encephalitis. J. Neuropathol. Exp. Neurol. 63 (2004), 631–640.
10. 10 Bush, T.G., et al. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 23 (1999), 297–308.
11. 11 Faulkner, J.R., et al. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 24 (2004), 2143–2155.
12. 12 Myer, D.J., et al. Essential protective roles of reactive astrocytes in traumatic brain injury. Brain 129 (2006), 2761–2772.
13. 13 Voskuhl, R.R., et al. Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J. Neurosci. 29 (2009), 11511–11522.
14. 14 Toft-Hansen, H., et al. Inhibition of reactive astrocytosis in established experimental autoimmune encephalomyelitis favors infiltration by myeloid cells over T cells and enhances severity of disease. Glia 59 (2011), 166–176.
15. 15 Mayo, L., et al. Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. Nat. Med. 20 (2014), 1147–1156.
16. 16 Anderson, M.A., et al. Astrocyte scar formation aids central nervous system axon regeneration. Nature 532 (2016), 195–200.
17. 17 Drogemuller, K., et al. Astrocyte gp130 expression is critical for the control of Toxoplasma encephalitis. J. Immunol. 181 (2008), 2683–2693.
18. 18 Haroon, F., et al. Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation. J. Immunol. 186 (2011), 6521–6531.
19. 19 Tebbutt, N.C., et al. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat. Med. 8 (2002), 1089–1097.
20. 20 Buckwalter, M.S., Wyss-Coray, T., Modelling neuroinflammatory phenotypes in vivo. J. Neuroinflammation, 1, 2004, 10.
21. 21 Doyle, K.P., et al. TGFβ signaling in the brain increases with aging and signals to astrocytes and innate immune cells in the weeks after stroke. J. Neuroinflammation, 7, 2010, 62.
22. 22 Cekanaviciute, E., et al. Astrocytic transforming growth factor-β signaling reduces subacute neuroinflammation after stroke in mice. Glia 62 (2014), 1227–1240.
23. 23 Cekanaviciute, E., et al. Astrocytic TGF-β signaling limits inflammation and reduces neuronal damage during central nervous system Toxoplasma infection. J. Immunol. 193 (2014), 139–149.
24. 24 Cho, M.L., et al. Transforming growth factor β1(TGF-β1) down-regulates TNFα-induced RANTES production in rheumatoid synovial fibroblasts through NF-κB-mediated transcriptional repression. Immunol. Lett. 105 (2006), 159–166.
25. 25 Horiuchi, M., et al. MEK-ERK signaling is involved in interferon-γ-induced death of oligodendroglial progenitor cells. J. Biol. Chem. 281 (2006), 20095–20106.
26. 26 Hu, X., Ivashkiv, L.B., Cross-regulation of signaling pathways by interferon-γ: implications for immune responses and autoimmune diseases. Immunity 31 (2009), 539–550.
27. 27 Krakowski, M., Owens, T., Interferon-γ confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26 (1996), 1641–1646.
28. 28 Willenborg, D.O., et al. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157 (1996), 3223–3227.
29. 29 Furlan, R., et al. Intrathecal delivery of IFN-γ protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes. J. Immunol. 167 (2001), 1821–1829.
30. 30 Hindinger, C., et al. IFN-γ signaling to astrocytes protects from autoimmune mediated neurological disability. PLoS One, 7, 2012, e42088.
31. 31 Gold, S.M., Voskuhl, R.R., Estrogen treatment in multiple sclerosis. J. Neurol. Sci. 286 (2009), 99–103.
32. 32 Spence, R.D., et al. Estrogen mediates neuroprotection and anti-inflammatory effects during EAE through ERα signaling on astrocytes but not through ERβ signaling on astrocytes or neurons. J. Neurosci. 33 (2013), 10924–10933.
33. 33 Tiwari-Woodruff, S., et al. Differential neuroprotective and anti-inflammatory effects of estrogen receptor (ER) α and ERβ ligand treatment. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 14813–14818.
34. 34 Spence, R.D., et al. Neuroprotection mediated through estrogen receptor-α in astrocytes. Proc. Natl. Acad. Sci. U.S.A. 108 (2011), 8867–8872.
35. 35 Colombo, E., et al. Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide. Ann. Neurol. 76 (2014), 325–337.
36. 36 Qian, Y., et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat. Immunol. 8 (2007), 247–256.
37. 37 Kang, Z., et al. Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. Immunity 32 (2010), 414–425.
38. 38 Kang, Z., et al. Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cells. Nat. Neurosci. 16 (2013), 1401–1408.
39. 39 Yan, Y., et al. CNS-specific therapy for ongoing EAE by silencing IL-17 pathway in astrocytes. Mol. Ther. 20 (2012), 1338–1348.
40. 40 Spiegel, S., Milstien, S., The outs and the ins of sphingosine-1-phosphate in immunity. Nat. Rev. Immunol. 11 (2011), 403–415.
41. 41 Fischer, I., et al. Sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 are functionally upregulated on astrocytes under proinflammatory conditions. PLoS One, 6, 2011, e23905.
42. 42 Choi, J.W., et al. FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation. Proc. Natl. Acad. Sci. U.S.A. 108 (2011), 751–756.
43. 43 Rostami, A., Ciric, B., Astrocyte-derived lactosylceramide implicated in multiple sclerosis. Nat. Med. 20 (2014), 1092–1093.
44. 44 Arevalo, J.C., Wu, S.H., Neurotrophin signaling: many exciting surprises!. Cell Mol. Life Sci. 63 (2006), 1523–1537.
45. 45 Colombo, E., et al. Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration. J. Exp. Med. 209 (2012), 521–535.
46. 46 Tak, P.P., Firestein, G.S., NF-κB: a key role in inflammatory diseases. J. Clin. Invest. 107 (2001), 7–11.
47. 47 Brambilla, R., et al. Inhibition of astroglial nuclear factor κB reduces inflammation and improves functional recovery after spinal cord injury. J. Exp. Med. 202 (2005), 145–156.
48. 48 Brambilla, R., et al. Transgenic inhibition of astroglial NF-κB improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation. J. Immunol. 182 (2009), 2628–2640.
49. 49 Brambilla, R., et al. Transgenic inhibition of astroglial NF-κB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis. J. Neuroinflammation, 9, 2012, 213.
50. 50 Brambilla, R., et al. Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination. Glia 62 (2014), 452–467.
51. 51 Fu, E.S., et al. Transgenic inhibition of glial NF-κB reduces pain behavior and inflammation after peripheral nerve injury. Pain 148 (2010), 509–518.
52. 52 Fuchtbauer, L., et al. Angiotensin II Type 1 receptor (AT1) signaling in astrocytes regulates synaptic degeneration-induced leukocyte entry to the central nervous system. Brain Behav. Immun. 25 (2011), 897–904.
53. 53 Khorooshi, R., et al. NF-κB-driven STAT2 and CCL2 expression in astrocytes in response to brain injury. J. Immunol. 181 (2008), 7284–7291.
54. 54 Dvoriantchikova, G., et al. Inactivation of astroglial NF-κB promotes survival of retinal neurons following ischemic injury. Eur. J. Neurosci. 30 (2009), 175–185.
55. 55 Barakat, D.J., et al. Astroglial NF-κB mediates oxidative stress by regulation of NADPH oxidase in a model of retinal ischemia reperfusion injury. J. Neurochem. 120 (2012), 586–597.
56. 56 Brambilla, R., et al. Transgenic inhibition of astroglial NF-κB leads to increased axonal sparing and sprouting following spinal cord injury. J. Neurochem. 110 (2009), 765–778.
57. 57 Raasch, J., et al. IκB kinase 2 determines oligodendrocyte loss by non-cell-autonomous activation of NF-κB in the central nervous system. Brain 134 (2011), 1184–1198.
58. 58 Wang, X., et al. Astrocytic A20 ameliorates experimental autoimmune encephalomyelitis by inhibiting NF-κB- and STAT1-dependent chemokine production in astrocytes. Acta Neuropathol. 126 (2013), 711–724.
59. 59 Nicolas, C.S., et al. The role of JAK-STAT signaling within the CNS. JAKSTAT, 2, 2013, e22925.
60. 60 Justicia, C., et al. Activation of the JAK/STAT pathway following transient focal cerebral ischemia: signaling through Jak1 and Stat3 in astrocytes. Glia 30 (2000), 253–270.
61. 61 Okada, S., et al. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat. Med. 12 (2006), 829–834.
62. 62 Herrmann, J.E., et al. STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J. Neurosci. 28 (2008), 7231–7243.
63. 63 O'Callaghan, J.P., et al. Early activation of STAT3 regulates reactive astrogliosis induced by diverse forms of neurotoxicity. PLoS One, 9, 2014, e102003.
64. 64 Nobuta, H., et al. STAT3-mediated astrogliosis protects myelin development in neonatal brain injury. Ann. Neurol. 72 (2012), 750–765.
65. 65 Wanner, I.B., et al. Glial scar borders are formed by newly proliferated, elongated astrocytes that interact to corral inflammatory and fibrotic cells via STAT3-dependent mechanisms after spinal cord injury. J. Neurosci. 33 (2013), 12870–12886.
66. 66 Pebay, A., et al. Sphingosine-1-phosphate induces proliferation of astrocytes: regulation by intracellular signalling cascades. Eur. J. Neurosci. 13 (2001), 2067–2076.
67. 67 Wu, C., et al. Dual effects of daily FTY720 on human astrocytes in vitro: relevance for neuroinflammation. J. Neuroinflammation, 10, 2013, 41.
68. 68 Hsieh, H.L., et al. Transforming growth factor-β1 induces matrix metalloproteinase-9 and cell migration in astrocytes: roles of ROS-dependent ERK- and JNK-NF-κB pathways. J. Neuroinflammation, 7, 2010, 88.
69. 69 Zhang, L., et al. Sex-related differences in MAPKs activation in rat astrocytes: effects of estrogen on cell death. Brain Res. Mol. Brain Res. 103 (2002), 1–11.
70. 70 Giraud, S.N., et al. Estradiol inhibits ongoing autoimmune neuroinflammation and NFκB-dependent CCL2 expression in reactive astrocytes. Proc. Natl. Acad. Sci. U.S.A. 107 (2010), 8416–8421.
71. 71 Ma, X., et al. IL-17 enhancement of the IL-6 signaling cascade in astrocytes. J. Immunol. 184 (2010), 4898–4906.
72. 72 Yi, H., et al. IL-17A induces MIP-1α expression in primary astrocytes via Src/MAPK/PI3 K/NF-κB pathways: implications for multiple sclerosis. J. Neuroimmune Pharmacol. 9 (2014), 629–641.
73. 73 Hamby, M.E., et al. Smad3-dependent signaling underlies the TGF-β1-mediated enhancement in astrocytic iNOS expression. Glia 58 (2010), 1282–1291.
74. 74 Meares, G.P., et al. Regulation of CCL20 expression in astrocytes by IL-6 and IL-17. Glia 60 (2012), 771–781.
75. 75 Park, E.J., et al. Rac1 contributes to maximal activation of STAT1 and STAT3 in IFN-γ-stimulated rat astrocytes. J. Immunol. 173 (2004), 5697–5703.
76. 76 Choi, W.H., et al. Anti-inflammatory roles of retinoic acid in rat brain astrocytes: Suppression of interferon-γ-induced JAK/STAT phosphorylation. Biochem. Biophys. Res. Commun. 329 (2005), 125–131.
77. 77 Babon, J.J., et al. Inhibition of IL-6 family cytokines by SOCS3. Semin. Immunol. 26 (2014), 13–19.
78. 78 Tong, Q., et al. VEGF is upregulated by hypoxia-induced mitogenic factor via the PI-3 K/Akt-NF-κB signaling pathway. Respir. Res., 7, 2006, 37.
79. 79 Lund, I.V., et al. BDNF selectively regulates GABAA receptor transcription by activation of the JAK/STAT pathway. Sci. Signal., 1, 2008, ra9.
80. 80 Islam, O., et al. Brain-derived neurotrophic factor (BDNF) has proliferative effects on neural stem cells through the truncated TRK-B receptor, MAP kinase, AKT, and STAT-3 signaling pathways. Curr. Neurovasc Res. 6 (2009), 42–53.
81. 81 Huang, D.R., et al. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J. Exp. Med. 193 (2001), 713–726.
82. 82 Paul, D., et al. Cell-selective knockout and 3D confocal image analysis reveals separate roles for astrocyte-and endothelial-derived CCL2 in neuroinflammation. J. Neuroinflammation, 11, 2014, 10.
83. 83 Moreno, M., et al. Conditional ablation of astroglial CCL2 suppresses CNS accumulation of M1 macrophages and preserves axons in mice with MOG peptide EAE. J. Neurosci. 34 (2014), 8175–8185.
84. 84 Kim, R.Y., et al. Astrocyte CCL2 sustains immune cell infiltration in chronic experimental autoimmune encephalomyelitis. J. Neuroimmunol. 274 (2014), 53–61.
85. 85 Mills Ko, E., et al. Deletion of astroglial CXCL10 delays clinical onset but does not affect progressive axon loss in a murine autoimmune multiple sclerosis model. J. Neuroinflammation, 11, 2014, 105.
86. 86 Argaw, A.T., et al. Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. J. Clin. Invest. 122 (2012), 2454–2468.
87. 87 Strasser, A., et al. The many roles of FAS receptor signaling in the immune system. Immunity 30 (2009), 180–192.
88. 88 Kohji, T., Matsumoto, Y., Coexpression of Fas/FasL and Bax on brain and infiltrating T cells in the central nervous system is closely associated with apoptotic cell death during autoimmune encephalomyelitis. J. Neuroimmunol. 106 (2000), 165–171.
89. 89 Wang, X., et al. Astrocytic Fas ligand expression is required to induce T-cell apoptosis and recovery from experimental autoimmune encephalomyelitis. Eur. J. Immunol. 43 (2013), 115–124.
90. 90 Linker, R.A., et al. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis. Brain 133 (2010), 2248–2263.
91. 91 Matyash, V., Kettenmann, H., Heterogeneity in astrocyte morphology and physiology. Brain Res. Rev. 63 (2010), 2–10.
92. 92 Kaltschmidt, B., et al. Signaling via NF-κB in the nervous system. Biochim. Biophys. Acta 1745 (2005), 287–299.
93. 93 Mattson, M.P., Camandola, S., NF-κB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 107 (2001), 247–254.
94. 94 van Loo, G., et al. Inhibition of transcription factor NF-κB in the central nervous system ameliorates autoimmune encephalomyelitis in mice. Nat. Immunol. 7 (2006), 954–961.
95. 95 Emmanouil, M., et al. Neuronal IκB kinase β protects mice from autoimmune encephalomyelitis by mediating neuroprotective and immunosuppressive effects in the central nervous system. J. Immunol. 183 (2009), 7877–7889.
96. 96 Cho, I.H., et al. Role of microglial IκKβ in kainic acid-induced hippocampal neuronal cell death. Brain 131 (2008), 3019–3033.
97. 97 Kaltschmidt, B., et al. Stimulus-dependent activation of NF-κB specifies apoptosis or neuroprotection in cerebellar granule cells. Neuromolecular Med. 2 (2002), 299–309.
98. 98 Chen, J., et al. SIRT1 protects against microglia-dependent amyloid-β toxicity through inhibiting NF-κB signaling. J. Biol. Chem. 280 (2005), 40364–40374.
99. 99 Mitchell, T.J., John, S., Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas. Immunology 114 (2005), 301–312.
100. 100 Zong, S., et al. The role of IL-17 promotes spinal cord neuroinflammation via activation of the transcription factor STAT3 after spinal cord injury in the rat. Mediators Inflamm., 2014, 2014, 786947.
101. 101 Dominguez, E., et al. SOCS3-mediated blockade of JAK/STAT3 signaling pathway reveals its major contribution to spinal cord neuroinflammation and mechanical allodynia after peripheral nerve injury. J. Neurosci. 30 (2010), 5754–5766.
102. 102 Pernet, V., et al. Misguidance and modulation of axonal regeneration by Stat3 and Rho/ROCK signaling in the transparent optic nerve. Cell. Death Dis., 4, 2013, e734.